What is the requirement for the labeling of the inner container of a mailed CII?

For a mailed prescription of a Schedule II controlled substance, the labeling of the inner container must adhere to specific regulations to ensure proper identification and safety. The requirement for the inner container to include details such as the patient's name and the prescription number, as well as pharmacy details, is critical in maintaining a clear chain of custody and ensuring that the substance can be traced back to the prescribing professional and pharmacy. This labeling plays a crucial role in preventing misuse, accidental ingestion, and facilitates the verification of the legitimacy of the prescription.

Including the prescription number helps in tracking the specific prescription in the pharmacy's records, providing a reference point in case of inquiries or issues related to the medication. The pharmacy details establish the source of the medication, giving recipients the necessary information to contact the pharmacy if there are questions or concerns regarding the medication.

The other options do not fulfill the regulatory requirements set forth for the labeling of a mailed CII. For instance, labeling that only includes the patient's name would not provide enough context about the medication or its origin. Similarly, the drug name alone lacks sufficient detail to ensure that the medication is properly identified and tracked. Lastly, omitting the labeling entirely would jeopardize safety and regulatory compliance. Hence, providing comprehensive information on the inner container